A new study identifies interleukin 11 as a marker of cancer-associated fibroblasts

Average-risk individuals may prefer stool-based test over colonoscopy for cancer screening

Improving survival in pancreatic cancer

Novel agent shows promise in treating the most aggressive type of breast cancer